LuciAnam 50 mg Tablet

Description

LuciAnam (Anamorelin) is a groundbreaking treatment designed specifically for cachexia in patients suffering from unresectable advanced and recurrent non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer. Each dose contains 50 mg of Anamorelin hydrochloride, providing a targeted solution for those facing the debilitating effects of cancer-related weight loss and appetite decline. Ideal for patients who have experienced a significant weight loss of more than 5% within the last six months and show signs of fatigue, malaise, or decreased muscle strength, LuciAnam addresses the critical needs of cancer cachexia patients. It is particularly effective for individuals who struggle with traditional nutritional therapies and have specific laboratory findings, such as a CRP value exceeding 0.5 mg/dL, hemoglobin levels below 12 g/dL, or albumin levels below 3.2 g/dL. By choosing LuciAnam (Anamorelin), patients can gain a renewed sense of hope and vitality in their fight against cancer, promoting better nutritional status and quality of life. Discover how LuciAnam can make a difference in your cancer care journey.